135P Characteristics and dosing patterns of US patients diagnosed with HR+/HER2- early breast cancer initiating abemaciclib at a lower dose than the approved 150mg BID

Spring, L.M. ; Gathirua-Mwangi, W.G. ; Kim, S. ; Richey, M. ; Cui, Z.L. ; Whipple, S. ; Wang, J. ; Liepa, A.M. ; Brechtelsbauer, E. ; Levoir, A. ; Volodarsky, R. ; Moreira, K. ; Rybowski, S. ; Soliman, H.

ESMO open, 2024-05, Vol.9, p.103122, Article 103122 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível